Astrazeneca Healthcare Foundation is categorized under Organizations in Wilmington, DE and active since 2010.
Astrazeneca Healthcare Foundation was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Organizations business, which does work in the BOTH market, and is classified as a Organizations, under code number 813410 by the NAICS.
If you are seeking more information, feel free to contact David R Brennan at the company’s single location by writing to 1800 Concord Pike, Wilmington, Delaware DE 19897 or by phoning (302) 886-3000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Astrazeneca Healthcare Foundation |
Contact Person: | David R Brennan |
Address: | 1800 Concord Pike, Wilmington, Delaware 19897 |
Phone Number: | (302) 886-3000 |
Website Address: | astrazeneca-us.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B & B2C |
Business Category: | Organizations |
SIC Code: | 8699 |
NAICS Code: | 813410 |
Share This Business: |
Astrazeneca Healthcare Foundation was started in 2010 to provide professional Organizations under the SIC code 8699 and NAICS code 813410. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David R Brennan for inquiries that concern Astrazeneca Healthcare Foundation by calling the company number (302) 886-3000, as your correspondence is most welcome. Additionally, the physical location of the single location of Astrazeneca Healthcare Foundation can be found at the coordinates 39.786283,-75.546334 as well as the street address 1800 Concord Pike in Wilmington, Delaware 19897.
For its online presence, you may visit Astrazeneca Healthcare Foundation’s website at astrazeneca-us.com and engage with its social media outlets through on Twitter and on Facebook.